Gene · 1672
Papers3,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of driver genes in lupus nephritis based on comprehensive bioinformatics and machine learning. | Front Immunol | 2023 | 38130724 | PubTator, text mining | PubMed |
| Retracted: Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach. | Comput Math Methods Med | 2023 | 38094444 | PubTator, text mining | PubMed |
| Application Value of Antimicrobial Peptides in Gastrointestinal Tumors. | Int J Mol Sci | 2023 | 38069041 | PubTator, text mining | PubMed |
| Ceragenins exhibit bactericidal properties that are independent of the ionic strength in the environment mimicking cystic fibrosis sputum. | Front Microbiol | 2023 | 38045035 | PubTator, text mining | PubMed |
| Prediction of disease recurrence or residual disease after primary endoscopic resection of pT1 colorectal cancer-results from a large nationwide Danish study. | Int J Colorectal Dis | 2023 | 38036699 | PubTator, text mining | PubMed |
| Machine learning for pan-cancer classification based on RNA sequencing data. | Front Mol Biosci | 2023 | 38028533 | PubTator, text mining | PubMed |
| Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer. | Explor Target Antitumor Ther | 2023 | 38023987 | PubTator, text mining | PubMed |
| Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting. | Int J Mol Sci | 2023 | 38003594 | PubTator, text mining | PubMed |
| Non-Invasive Assessment of Skin Surface Proteins of Psoriasis Vulgaris Patients in Response to Biological Therapy. | Int J Mol Sci | 2023 | 38003437 | PubTator, text mining | PubMed |
| Prognostic Value of Tumor Budding for Early Breast Cancer. | Biomedicines | 2023 | 38001907 | PubTator, text mining | PubMed |
| The potential of BRD4 inhibition in tumour mechanosignaling. | J Cell Mol Med | 2023 | 37994501 | PubTator, text mining | PubMed |
| mRNA display reveals a class of high-affinity bromodomain-binding motifs that are not found in the human proteome. | J Biol Chem | 2023 | 37992806 | PubTator, text mining | PubMed |
| Revealing the potential of necroptosis-related genes in prognosis, immune characteristics, and treatment strategies for head and neck squamous cell carcinoma. | Sci Rep | 2023 | 37989855 | PubTator, text mining | PubMed |
| Association between polymorphisms of immune response genes and early childhood caries - systematic review, gene-based, gene cluster, and meta-analysis. | J Genet Eng Biotechnol | 2023 | 37971556 | PubTator, text mining | PubMed |
| A single-cell atlas depicting the cellular and molecular features in human anterior cruciate ligamental degeneration: A single cell combined spatial transcriptomics study. | Elife | 2023 | 37970848 | PubTator, text mining | PubMed |
| Structure-Guided Design of a Domain-Selective Bromodomain and Extra Terminal N-Terminal Bromodomain Chemical Probe. | J Med Chem | 2023 | 37967462 | PubTator, text mining | PubMed |
| Interactome between ASFV and host immune pathway proteins. | mSystems | 2023 | 37966252 | PubTator, text mining | PubMed |
| Increasing expression of STING by ERα antagonizes LCN2 downregulation during chronic endometritis. | J Reprod Immunol | 2023 | 37952294 | PubTator, text mining | PubMed |
| Preoperative prediction of tumor budding in rectal cancer using multiple machine learning algorithms based on MRI T2WI radiomics. | Front Oncol | 2023 | 37941552 | PubTator, text mining | PubMed |
| Peptide-based approaches to directly target alpha-synuclein in Parkinson's disease. | Mol Neurodegener | 2023 | 37940962 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1672/papers?page=11